Clarus Therapeutics Reports First Quarter 2022 Financial and Operating Results
Go back to Clarus Therapeutics Reports First Quarter 2022 Financial and Operating Results| (NASDAQ: CRXT) | Delayed: 0.10 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.10 | 52 Week High | $ | |||
| Open | $0.17 | 52 Week Low | $ | |||
| Day High | $0.10 | P/E | N/A | |||
| Day Low | $0.10 | EPS | $ | |||
| Volume | 13,955 | |||||
| (NASDAQ: CRXTW) | Delayed: 0.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $ | |||
| Open | $1.08 | 52 Week Low | $ | |||
| Day High | $0.01 | P/E | N/A | |||
| Day Low | $0.01 | EPS | $ | |||
| Volume | 734,363 | |||||

